nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—ABCB1—ovarian cancer	0.379	1	CbGaD
Olanzapine—ABCB1—Topotecan—ovarian cancer	0.0439	0.168	CbGbCtD
Olanzapine—ABCB1—Vinorelbine—ovarian cancer	0.0309	0.119	CbGbCtD
Olanzapine—CYP2D6—Vinorelbine—ovarian cancer	0.0291	0.112	CbGbCtD
Olanzapine—CYP3A4—Topotecan—ovarian cancer	0.0263	0.101	CbGbCtD
Olanzapine—CYP2C9—Paclitaxel—ovarian cancer	0.0224	0.0858	CbGbCtD
Olanzapine—ABCB1—Paclitaxel—ovarian cancer	0.0217	0.0833	CbGbCtD
Olanzapine—CYP3A4—Vinorelbine—ovarian cancer	0.0185	0.071	CbGbCtD
Olanzapine—ABCB1—Docetaxel—ovarian cancer	0.0157	0.0602	CbGbCtD
Olanzapine—CHRM3—muscle of abdomen—ovarian cancer	0.0153	0.0745	CbGeAlD
Olanzapine—CYP3A4—Paclitaxel—ovarian cancer	0.013	0.0499	CbGbCtD
Olanzapine—ABCB1—Doxorubicin—ovarian cancer	0.0117	0.0449	CbGbCtD
Olanzapine—HTR7—vein—ovarian cancer	0.0112	0.0546	CbGeAlD
Olanzapine—H1F0—oviduct—ovarian cancer	0.0112	0.0545	CbGeAlD
Olanzapine—CYP2D6—Doxorubicin—ovarian cancer	0.011	0.0423	CbGbCtD
Olanzapine—CYP3A4—Docetaxel—ovarian cancer	0.0094	0.0361	CbGbCtD
Olanzapine—CYP3A4—Doxorubicin—ovarian cancer	0.00701	0.0269	CbGbCtD
Olanzapine—HTR2A—vein—ovarian cancer	0.007	0.0341	CbGeAlD
Olanzapine—HTR1E—myometrium—ovarian cancer	0.00605	0.0295	CbGeAlD
Olanzapine—HRH4—bone marrow—ovarian cancer	0.0057	0.0277	CbGeAlD
Olanzapine—H1F0—myometrium—ovarian cancer	0.00358	0.0174	CbGeAlD
Olanzapine—H1F0—embryo—ovarian cancer	0.00344	0.0168	CbGeAlD
Olanzapine—DRD4—testis—ovarian cancer	0.0033	0.0161	CbGeAlD
Olanzapine—CHRM5—epithelium—ovarian cancer	0.00326	0.0159	CbGeAlD
Olanzapine—HTR1E—female gonad—ovarian cancer	0.00321	0.0156	CbGeAlD
Olanzapine—H1F0—uterine cervix—ovarian cancer	0.00279	0.0136	CbGeAlD
Olanzapine—DRD5—female reproductive system—ovarian cancer	0.0027	0.0131	CbGeAlD
Olanzapine—H1F0—decidua—ovarian cancer	0.00265	0.0129	CbGeAlD
Olanzapine—HTR2B—myometrium—ovarian cancer	0.00258	0.0126	CbGeAlD
Olanzapine—FMO3—vagina—ovarian cancer	0.00257	0.0125	CbGeAlD
Olanzapine—H1F0—endometrium—ovarian cancer	0.00252	0.0123	CbGeAlD
Olanzapine—CHRM4—testis—ovarian cancer	0.0025	0.0122	CbGeAlD
Olanzapine—DRD5—female gonad—ovarian cancer	0.00245	0.0119	CbGeAlD
Olanzapine—H1F0—gonad—ovarian cancer	0.00234	0.0114	CbGeAlD
Olanzapine—H1F0—uterus—ovarian cancer	0.00232	0.0113	CbGeAlD
Olanzapine—FMO3—testis—ovarian cancer	0.0023	0.0112	CbGeAlD
Olanzapine—ORM1—endometrium—ovarian cancer	0.00215	0.0105	CbGeAlD
Olanzapine—H1F0—female reproductive system—ovarian cancer	0.00209	0.0102	CbGeAlD
Olanzapine—ADRA2C—myometrium—ovarian cancer	0.00203	0.00988	CbGeAlD
Olanzapine—HTR2B—uterine cervix—ovarian cancer	0.00201	0.00977	CbGeAlD
Olanzapine—H1F0—bone marrow—ovarian cancer	0.00197	0.00959	CbGeAlD
Olanzapine—HTR2B—decidua—ovarian cancer	0.00191	0.00931	CbGeAlD
Olanzapine—H1F0—female gonad—ovarian cancer	0.0019	0.00925	CbGeAlD
Olanzapine—H1F0—vagina—ovarian cancer	0.00189	0.00919	CbGeAlD
Olanzapine—HTR2B—endometrium—ovarian cancer	0.00182	0.00884	CbGeAlD
Olanzapine—ORM1—female reproductive system—ovarian cancer	0.00178	0.00867	CbGeAlD
Olanzapine—HTR7—epithelium—ovarian cancer	0.00173	0.00844	CbGeAlD
Olanzapine—H1F0—testis—ovarian cancer	0.00168	0.0082	CbGeAlD
Olanzapine—ORM1—bone marrow—ovarian cancer	0.00168	0.00819	CbGeAlD
Olanzapine—HTR2B—uterus—ovarian cancer	0.00167	0.00814	CbGeAlD
Olanzapine—ADRA1A—epithelium—ovarian cancer	0.00167	0.00814	CbGeAlD
Olanzapine—HTR1B—female reproductive system—ovarian cancer	0.00167	0.00813	CbGeAlD
Olanzapine—FMO3—lymph node—ovarian cancer	0.00166	0.0081	CbGeAlD
Olanzapine—HRH1—myometrium—ovarian cancer	0.00165	0.00803	CbGeAlD
Olanzapine—ADRA2A—myometrium—ovarian cancer	0.00162	0.00789	CbGeAlD
Olanzapine—HTR1D—female reproductive system—ovarian cancer	0.00162	0.00787	CbGeAlD
Olanzapine—HTR2C—female reproductive system—ovarian cancer	0.0016	0.00779	CbGeAlD
Olanzapine—ADRA2C—uterine cervix—ovarian cancer	0.00158	0.00769	CbGeAlD
Olanzapine—CHRM1—female reproductive system—ovarian cancer	0.00151	0.00736	CbGeAlD
Olanzapine—ADRA2C—decidua—ovarian cancer	0.00151	0.00733	CbGeAlD
Olanzapine—HTR2B—female reproductive system—ovarian cancer	0.0015	0.00732	CbGeAlD
Olanzapine—HRH2—lymph node—ovarian cancer	0.00148	0.00721	CbGeAlD
Olanzapine—HTR7—gonad—ovarian cancer	0.00144	0.00702	CbGeAlD
Olanzapine—ADRA2C—endometrium—ovarian cancer	0.00143	0.00696	CbGeAlD
Olanzapine—HTR2B—vagina—ovarian cancer	0.00136	0.00662	CbGeAlD
Olanzapine—CHRM3—female reproductive system—ovarian cancer	0.00135	0.00659	CbGeAlD
Olanzapine—HTR2A—embryo—ovarian cancer	0.00132	0.00645	CbGeAlD
Olanzapine—ADRA2C—uterus—ovarian cancer	0.00132	0.00641	CbGeAlD
Olanzapine—HRH1—epithelium—ovarian cancer	0.00129	0.0063	CbGeAlD
Olanzapine—HTR7—female reproductive system—ovarian cancer	0.00129	0.00627	CbGeAlD
Olanzapine—HRH1—uterine cervix—ovarian cancer	0.00128	0.00625	CbGeAlD
Olanzapine—ADRA2A—uterine cervix—ovarian cancer	0.00126	0.00614	CbGeAlD
Olanzapine—ALB—testis—ovarian cancer	0.00126	0.00614	CbGeAlD
Olanzapine—CHRM3—female gonad—ovarian cancer	0.00123	0.00599	CbGeAlD
Olanzapine—HRH1—decidua—ovarian cancer	0.00122	0.00595	CbGeAlD
Olanzapine—H1F0—lymph node—ovarian cancer	0.00122	0.00594	CbGeAlD
Olanzapine—ADRA2A—decidua—ovarian cancer	0.0012	0.00585	CbGeAlD
Olanzapine—HRH1—endometrium—ovarian cancer	0.00116	0.00565	CbGeAlD
Olanzapine—ADRA2A—endometrium—ovarian cancer	0.00114	0.00555	CbGeAlD
Olanzapine—CYP2C19—vagina—ovarian cancer	0.00114	0.00554	CbGeAlD
Olanzapine—CHRM3—testis—ovarian cancer	0.00109	0.00532	CbGeAlD
Olanzapine—HTR2A—epithelium—ovarian cancer	0.00108	0.00526	CbGeAlD
Olanzapine—ADRA2C—female gonad—ovarian cancer	0.00108	0.00524	CbGeAlD
Olanzapine—ADRA2C—vagina—ovarian cancer	0.00107	0.00521	CbGeAlD
Olanzapine—ADRA2A—gonad—ovarian cancer	0.00106	0.00515	CbGeAlD
Olanzapine—ADRA2A—uterus—ovarian cancer	0.00105	0.00511	CbGeAlD
Olanzapine—ORM1—lymph node—ovarian cancer	0.00104	0.00507	CbGeAlD
Olanzapine—HTR7—testis—ovarian cancer	0.00104	0.00506	CbGeAlD
Olanzapine—DRD2—testis—ovarian cancer	0.000983	0.00478	CbGeAlD
Olanzapine—CYP2C9—female reproductive system—ovarian cancer	0.000975	0.00475	CbGeAlD
Olanzapine—HRH1—female reproductive system—ovarian cancer	0.000961	0.00468	CbGeAlD
Olanzapine—ADRA2C—testis—ovarian cancer	0.000955	0.00465	CbGeAlD
Olanzapine—ADRA2A—female reproductive system—ovarian cancer	0.000944	0.0046	CbGeAlD
Olanzapine—ALB—lymph node—ovarian cancer	0.000914	0.00445	CbGeAlD
Olanzapine—ABCB1—myometrium—ovarian cancer	0.000903	0.00439	CbGeAlD
Olanzapine—HTR2A—gonad—ovarian cancer	0.000899	0.00438	CbGeAlD
Olanzapine—HTR2B—lymph node—ovarian cancer	0.00088	0.00428	CbGeAlD
Olanzapine—HRH1—female gonad—ovarian cancer	0.000875	0.00426	CbGeAlD
Olanzapine—HRH1—vagina—ovarian cancer	0.00087	0.00423	CbGeAlD
Olanzapine—ABCB1—embryo—ovarian cancer	0.000868	0.00423	CbGeAlD
Olanzapine—ADRA2A—female gonad—ovarian cancer	0.000859	0.00418	CbGeAlD
Olanzapine—ADRA2A—vagina—ovarian cancer	0.000854	0.00416	CbGeAlD
Olanzapine—HTR2A—female reproductive system—ovarian cancer	0.000803	0.00391	CbGeAlD
Olanzapine—HRH1—testis—ovarian cancer	0.000776	0.00378	CbGeAlD
Olanzapine—ADRA2A—testis—ovarian cancer	0.000762	0.00371	CbGeAlD
Olanzapine—CYP3A4—female reproductive system—ovarian cancer	0.000743	0.00362	CbGeAlD
Olanzapine—CYP2D6—female reproductive system—ovarian cancer	0.000732	0.00356	CbGeAlD
Olanzapine—HTR2A—vagina—ovarian cancer	0.000726	0.00354	CbGeAlD
Olanzapine—ABCB1—epithelium—ovarian cancer	0.000708	0.00345	CbGeAlD
Olanzapine—ABCB1—uterine cervix—ovarian cancer	0.000702	0.00342	CbGeAlD
Olanzapine—ADRA2C—lymph node—ovarian cancer	0.000692	0.00337	CbGeAlD
Olanzapine—ABCB1—decidua—ovarian cancer	0.000669	0.00326	CbGeAlD
Olanzapine—CYP2D6—female gonad—ovarian cancer	0.000666	0.00324	CbGeAlD
Olanzapine—HTR2A—testis—ovarian cancer	0.000648	0.00316	CbGeAlD
Olanzapine—ABCB1—endometrium—ovarian cancer	0.000635	0.00309	CbGeAlD
Olanzapine—CYP2D6—testis—ovarian cancer	0.00059	0.00287	CbGeAlD
Olanzapine—ABCB1—gonad—ovarian cancer	0.000589	0.00287	CbGeAlD
Olanzapine—ABCB1—uterus—ovarian cancer	0.000585	0.00285	CbGeAlD
Olanzapine—HRH1—lymph node—ovarian cancer	0.000562	0.00274	CbGeAlD
Olanzapine—ADRA2A—lymph node—ovarian cancer	0.000552	0.00269	CbGeAlD
Olanzapine—ABCB1—female reproductive system—ovarian cancer	0.000526	0.00256	CbGeAlD
Olanzapine—ABCB1—bone marrow—ovarian cancer	0.000497	0.00242	CbGeAlD
Olanzapine—ABCB1—female gonad—ovarian cancer	0.000479	0.00233	CbGeAlD
Olanzapine—ABCB1—vagina—ovarian cancer	0.000476	0.00232	CbGeAlD
Olanzapine—ABCB1—testis—ovarian cancer	0.000425	0.00207	CbGeAlD
Olanzapine—ABCB1—lymph node—ovarian cancer	0.000308	0.0015	CbGeAlD
Olanzapine—Clozapine—CYP1B1—ovarian cancer	2.32e-05	0.617	CrCbGaD
Olanzapine—CHRM3—Signaling Pathways—PTEN—ovarian cancer	8.23e-06	5.29e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MAPK3—ovarian cancer	8.21e-06	5.28e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CDKN1B—ovarian cancer	8.2e-06	5.28e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MMP9—ovarian cancer	8.2e-06	5.27e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—STAT3—ovarian cancer	8.18e-06	5.26e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MMP9—ovarian cancer	8.17e-06	5.26e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MAPK3—ovarian cancer	8.17e-06	5.25e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—NRAS—ovarian cancer	8.16e-06	5.25e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PTEN—ovarian cancer	8.15e-06	5.24e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PTEN—ovarian cancer	8.13e-06	5.23e-05	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—AKT1—ovarian cancer	8.11e-06	5.22e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—IL6—ovarian cancer	8.11e-06	5.22e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—HRAS—ovarian cancer	8.1e-06	5.21e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—IL6—ovarian cancer	8.1e-06	5.21e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—AKT1—ovarian cancer	8.1e-06	5.21e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MAPK1—ovarian cancer	8.09e-06	5.21e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—EGFR—ovarian cancer	8.09e-06	5.2e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TP53—ovarian cancer	8.09e-06	5.2e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—AKT1—ovarian cancer	8.08e-06	5.2e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ABCB1—ovarian cancer	8.06e-06	5.19e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—AKT1—ovarian cancer	8.05e-06	5.18e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—IL6—ovarian cancer	8.05e-06	5.18e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CASP3—ovarian cancer	8.04e-06	5.17e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—AKT1—ovarian cancer	8.03e-06	5.16e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL2—ovarian cancer	8.03e-06	5.16e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TP53—ovarian cancer	8e-06	5.15e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—HRAS—ovarian cancer	7.99e-06	5.14e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—IL6—ovarian cancer	7.99e-06	5.14e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MYC—ovarian cancer	7.98e-06	5.14e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—AKT1—ovarian cancer	7.95e-06	5.11e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MAPK3—ovarian cancer	7.94e-06	5.11e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MYC—ovarian cancer	7.94e-06	5.11e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—AKT1—ovarian cancer	7.93e-06	5.1e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—TYMS—ovarian cancer	7.92e-06	5.09e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.9e-06	5.08e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—PIK3CA—ovarian cancer	7.88e-06	5.07e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IL6—ovarian cancer	7.88e-06	5.07e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—PIK3CA—ovarian cancer	7.84e-06	5.05e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CCND1—ovarian cancer	7.82e-06	5.03e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MAPK3—ovarian cancer	7.82e-06	5.03e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	7.81e-06	5.03e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MAPK1—ovarian cancer	7.81e-06	5.02e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EGFR—ovarian cancer	7.81e-06	5.02e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—PIK3CA—ovarian cancer	7.78e-06	5e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MAPK1—ovarian cancer	7.77e-06	5e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EGFR—ovarian cancer	7.77e-06	5e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IL6—ovarian cancer	7.75e-06	4.99e-05	CbGpPWpGaD
Olanzapine—Quetiapine—ABCB1—ovarian cancer	7.75e-06	0.206	CrCbGaD
Olanzapine—ADRA2A—Signaling Pathways—CTNNB1—ovarian cancer	7.75e-06	4.98e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	7.75e-06	4.98e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—HRAS—ovarian cancer	7.73e-06	4.97e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MYC—ovarian cancer	7.73e-06	4.97e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—HRAS—ovarian cancer	7.65e-06	4.92e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IL6—ovarian cancer	7.65e-06	4.92e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—KRAS—ovarian cancer	7.64e-06	4.92e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TP53—ovarian cancer	7.63e-06	4.91e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VEGFA—ovarian cancer	7.62e-06	4.9e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MYC—ovarian cancer	7.6e-06	4.89e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MMP9—ovarian cancer	7.6e-06	4.89e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MAPK1—ovarian cancer	7.56e-06	4.86e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EGFR—ovarian cancer	7.56e-06	4.86e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PTEN—ovarian cancer	7.55e-06	4.86e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—STAT3—ovarian cancer	7.54e-06	4.85e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	7.53e-06	4.84e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—NRAS—ovarian cancer	7.53e-06	4.84e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TP53—ovarian cancer	7.52e-06	4.84e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	7.5e-06	4.82e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VEGFA—ovarian cancer	7.48e-06	4.81e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—AKT1—ovarian cancer	7.48e-06	4.81e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—AKT1—ovarian cancer	7.47e-06	4.81e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VEGFA—ovarian cancer	7.46e-06	4.8e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MAPK1—ovarian cancer	7.44e-06	4.79e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EGFR—ovarian cancer	7.44e-06	4.78e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VEGFA—ovarian cancer	7.43e-06	4.78e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—AKT1—ovarian cancer	7.42e-06	4.78e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—STAT3—ovarian cancer	7.42e-06	4.78e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—STAT3—ovarian cancer	7.41e-06	4.77e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—NRAS—ovarian cancer	7.41e-06	4.76e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	7.4e-06	4.76e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IL6—ovarian cancer	7.4e-06	4.76e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—NRAS—ovarian cancer	7.39e-06	4.75e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—STAT3—ovarian cancer	7.38e-06	4.75e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—KRAS—ovarian cancer	7.38e-06	4.75e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—AKT1—ovarian cancer	7.37e-06	4.74e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—NRAS—ovarian cancer	7.37e-06	4.74e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VEGFA—ovarian cancer	7.36e-06	4.74e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—STAT3—ovarian cancer	7.36e-06	4.73e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—NRAS—ovarian cancer	7.34e-06	4.72e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VEGFA—ovarian cancer	7.34e-06	4.72e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—KRAS—ovarian cancer	7.34e-06	4.72e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IL6—ovarian cancer	7.32e-06	4.71e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—HRAS—ovarian cancer	7.29e-06	4.69e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—STAT3—ovarian cancer	7.29e-06	4.69e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—NRAS—ovarian cancer	7.27e-06	4.68e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—AKT1—ovarian cancer	7.27e-06	4.68e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—STAT3—ovarian cancer	7.27e-06	4.68e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—NRAS—ovarian cancer	7.25e-06	4.66e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CB—ovarian cancer	7.23e-06	4.65e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MAPK3—ovarian cancer	7.21e-06	4.64e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—HRAS—ovarian cancer	7.2e-06	4.63e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—AKT1—ovarian cancer	7.15e-06	4.6e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—KRAS—ovarian cancer	7.14e-06	4.59e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTEN—ovarian cancer	7.13e-06	4.59e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	7.09e-06	4.56e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MAPK3—ovarian cancer	7.08e-06	4.55e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—AKT1—ovarian cancer	7.06e-06	4.54e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MAPK3—ovarian cancer	7.05e-06	4.54e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MAPK3—ovarian cancer	7.03e-06	4.52e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—KRAS—ovarian cancer	7.03e-06	4.52e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—PIK3CA—ovarian cancer	7.02e-06	4.52e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MYC—ovarian cancer	7.01e-06	4.51e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IL6—ovarian cancer	6.98e-06	4.49e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MAPK3—ovarian cancer	6.96e-06	4.48e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MAPK3—ovarian cancer	6.94e-06	4.47e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—PIK3CA—ovarian cancer	6.94e-06	4.47e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MYC—ovarian cancer	6.9e-06	4.44e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IL6—ovarian cancer	6.89e-06	4.43e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MYC—ovarian cancer	6.88e-06	4.43e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MYC—ovarian cancer	6.86e-06	4.41e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MAPK1—ovarian cancer	6.86e-06	4.41e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EGFR—ovarian cancer	6.86e-06	4.41e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MYC—ovarian cancer	6.84e-06	4.4e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—AKT1—ovarian cancer	6.83e-06	4.39e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VEGFA—ovarian cancer	6.82e-06	4.39e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	6.81e-06	4.38e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TP53—ovarian cancer	6.79e-06	4.37e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—PIK3CA—ovarian cancer	6.78e-06	4.36e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MYC—ovarian cancer	6.77e-06	4.36e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—AKT1—ovarian cancer	6.76e-06	4.35e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MYC—ovarian cancer	6.75e-06	4.34e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—STAT3—ovarian cancer	6.75e-06	4.34e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	6.75e-06	4.34e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	6.75e-06	4.34e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EGFR—ovarian cancer	6.75e-06	4.34e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—PIK3CA—ovarian cancer	6.74e-06	4.34e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NRAS—ovarian cancer	6.74e-06	4.33e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MAPK1—ovarian cancer	6.73e-06	4.33e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EGFR—ovarian cancer	6.73e-06	4.33e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MAPK1—ovarian cancer	6.71e-06	4.32e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EGFR—ovarian cancer	6.71e-06	4.32e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MAPK1—ovarian cancer	6.69e-06	4.3e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EGFR—ovarian cancer	6.69e-06	4.3e-05	CbGpPWpGaD
Olanzapine—Clozapine—ABCB1—ovarian cancer	6.66e-06	0.177	CrCbGaD
Olanzapine—CHRM2—Signaling Pathways—MAPK1—ovarian cancer	6.63e-06	4.26e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EGFR—ovarian cancer	6.62e-06	4.26e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	6.62e-06	4.26e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MAPK1—ovarian cancer	6.61e-06	4.25e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EGFR—ovarian cancer	6.61e-06	4.25e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—PIK3CA—ovarian cancer	6.56e-06	4.22e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TP53—ovarian cancer	6.56e-06	4.22e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TP53—ovarian cancer	6.52e-06	4.2e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—HRAS—ovarian cancer	6.5e-06	4.18e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—KRAS—ovarian cancer	6.48e-06	4.17e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—PIK3CA—ovarian cancer	6.45e-06	4.15e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MAPK3—ovarian cancer	6.45e-06	4.15e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—AKT1—ovarian cancer	6.44e-06	4.14e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—AKT1—ovarian cancer	6.41e-06	4.12e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTEN—ovarian cancer	6.4e-06	4.12e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CAV1—ovarian cancer	6.38e-06	4.1e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—KRAS—ovarian cancer	6.37e-06	4.1e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PIK3CA—ovarian cancer	6.37e-06	4.1e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—KRAS—ovarian cancer	6.36e-06	4.09e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—AKT1—ovarian cancer	6.35e-06	4.09e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TP53—ovarian cancer	6.34e-06	4.08e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—KRAS—ovarian cancer	6.34e-06	4.08e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—KRAS—ovarian cancer	6.32e-06	4.07e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MYC—ovarian cancer	6.28e-06	4.04e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—HRAS—ovarian cancer	6.27e-06	4.03e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—KRAS—ovarian cancer	6.26e-06	4.03e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTEN—ovarian cancer	6.24e-06	4.02e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TP53—ovarian cancer	6.24e-06	4.02e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—KRAS—ovarian cancer	6.24e-06	4.01e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—HRAS—ovarian cancer	6.24e-06	4.01e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IL6—ovarian cancer	6.22e-06	4e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MAPK1—ovarian cancer	6.14e-06	3.95e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EGFR—ovarian cancer	6.14e-06	3.95e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—HRAS—ovarian cancer	6.07e-06	3.9e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IL6—ovarian cancer	6e-06	3.86e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—HRAS—ovarian cancer	5.97e-06	3.84e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IL6—ovarian cancer	5.97e-06	3.84e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	5.95e-06	3.83e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTEN—ovarian cancer	5.88e-06	3.79e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	5.86e-06	3.77e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PIK3CA—ovarian cancer	5.84e-06	3.76e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTEN—ovarian cancer	5.83e-06	3.75e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PIK3CA—ovarian cancer	5.82e-06	3.75e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	5.81e-06	3.74e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IL6—ovarian cancer	5.81e-06	3.74e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PIK3CA—ovarian cancer	5.81e-06	3.73e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—KRAS—ovarian cancer	5.8e-06	3.73e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	5.77e-06	3.71e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TP53—ovarian cancer	5.76e-06	3.7e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PIK3CA—ovarian cancer	5.75e-06	3.7e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—AKT1—ovarian cancer	5.74e-06	3.69e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PIK3CA—ovarian cancer	5.73e-06	3.69e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL6—ovarian cancer	5.72e-06	3.68e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—AKT1—ovarian cancer	5.67e-06	3.65e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TP53—ovarian cancer	5.66e-06	3.64e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TP53—ovarian cancer	5.65e-06	3.64e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TP53—ovarian cancer	5.63e-06	3.62e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TP53—ovarian cancer	5.62e-06	3.61e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TP53—ovarian cancer	5.56e-06	3.58e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TP53—ovarian cancer	5.55e-06	3.57e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—AKT1—ovarian cancer	5.54e-06	3.56e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—AKT1—ovarian cancer	5.51e-06	3.54e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—HRAS—ovarian cancer	5.51e-06	3.54e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—HRAS—ovarian cancer	5.42e-06	3.49e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—HRAS—ovarian cancer	5.41e-06	3.48e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—HRAS—ovarian cancer	5.39e-06	3.47e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—HRAS—ovarian cancer	5.37e-06	3.46e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—AKT1—ovarian cancer	5.36e-06	3.45e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PIK3CA—ovarian cancer	5.33e-06	3.43e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—HRAS—ovarian cancer	5.32e-06	3.42e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—HRAS—ovarian cancer	5.3e-06	3.41e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—AKT1—ovarian cancer	5.27e-06	3.39e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL6—ovarian cancer	5.27e-06	3.39e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—AKT1—ovarian cancer	5.2e-06	3.35e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL6—ovarian cancer	5.19e-06	3.34e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL6—ovarian cancer	5.17e-06	3.33e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL6—ovarian cancer	5.16e-06	3.32e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TP53—ovarian cancer	5.15e-06	3.32e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL6—ovarian cancer	5.14e-06	3.31e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	5.11e-06	3.29e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL6—ovarian cancer	5.09e-06	3.28e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL6—ovarian cancer	5.08e-06	3.27e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PIK3CA—ovarian cancer	5.03e-06	3.23e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTEN—ovarian cancer	4.99e-06	3.21e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—HRAS—ovarian cancer	4.93e-06	3.17e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—AKT1—ovarian cancer	4.86e-06	3.13e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—AKT1—ovarian cancer	4.78e-06	3.08e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—AKT1—ovarian cancer	4.77e-06	3.07e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—AKT1—ovarian cancer	4.76e-06	3.06e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—AKT1—ovarian cancer	4.74e-06	3.05e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL6—ovarian cancer	4.72e-06	3.03e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—AKT1—ovarian cancer	4.7e-06	3.02e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—AKT1—ovarian cancer	4.68e-06	3.01e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	4.51e-06	2.9e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	4.45e-06	2.86e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CA—ovarian cancer	4.41e-06	2.83e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—AKT1—ovarian cancer	4.35e-06	2.8e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	4.15e-06	2.67e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	4.12e-06	2.65e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—AKT1—ovarian cancer	4.11e-06	2.64e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTEN—ovarian cancer	3.85e-06	2.48e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—AKT1—ovarian cancer	3.69e-06	2.37e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—AKT1—ovarian cancer	3.6e-06	2.32e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	3.52e-06	2.26e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—AKT1—ovarian cancer	3.39e-06	2.18e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—AKT1—ovarian cancer	3.36e-06	2.16e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AKT1—ovarian cancer	2.87e-06	1.85e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.71e-06	1.75e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AKT1—ovarian cancer	2.22e-06	1.43e-05	CbGpPWpGaD
